June 23, 2011 09:30 ET

CDEX Taps Public Safety Industry Veteran as Director of Outside Sales

Company Begins Expansion of Domestic and International Sales Force

TUCSON, AZ--(Marketwire - Jun 23, 2011) - CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products, using patented technologies, for use in healthcare, safety and security markets, announced today public safety industry veteran John McConnell has joined its team as Director of Outside Sales.

McConnell's professional background spans more than 20 years as an advisor and senior executive with several leading security and technology companies. Prior to joining CDEX, McConnell was the vice president of sales and marketing at Soncell North America (NA), Inc., parent company of Decatur Electronics, Inc., where he was instrumental in the integration and management of more than 50 direct public safety sales team members. Previous to Soncell NA, he held the director of sales position with Integrian, Inc., was co-founder and vice president of sales / business development with Digital Safety Technologies, Inc., and served in various executive and sales management positions with other companies.

At CDEX, McConnell will be responsible for building a network of sales channel leaders to identify, target and sell the ID2 product line nationally and internationally.

"We are very excited to have John join our team. He brings high energy and a wealth of industry knowledge, expertise and contacts which should immediately benefit our sales pipeline," stated Jeff Brumfield, chairman and chief executive officer of CDEX. "John has already secured several new agents and is working feverishly to spread the word regarding our Pocket ID2 detection device. We continue to build the necessary infrastructure and support to execute our business plan and drive future sales."

About CDEX
CDEX develops, manufactures and globally distributes products to the healthcare, safety and security markets. The ValiMed™ product line provides life-saving validation of high-risk medications and pharmacy returned narcotics. The ID2™ product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets in the future where its proprietary products can be launched. To learn more about CDEX please visit:

Safe Harbor Statement
Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "believes," "should," "intends," and similar words. These statements pose risks that cannot be accurately predicted. Consequently, results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.

Contact Information